AU619613B2 - Lactamimides in the treatment of drug-resistant protozoal infections - Google Patents

Lactamimides in the treatment of drug-resistant protozoal infections Download PDF

Info

Publication number
AU619613B2
AU619613B2 AU44450/89A AU4445089A AU619613B2 AU 619613 B2 AU619613 B2 AU 619613B2 AU 44450/89 A AU44450/89 A AU 44450/89A AU 4445089 A AU4445089 A AU 4445089A AU 619613 B2 AU619613 B2 AU 619613B2
Authority
AU
Australia
Prior art keywords
carbon atoms
group
drug
phenyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44450/89A
Other languages
English (en)
Other versions
AU4445089A (en
Inventor
Alan J. Bitonti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of AU4445089A publication Critical patent/AU4445089A/en
Application granted granted Critical
Publication of AU619613B2 publication Critical patent/AU619613B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU44450/89A 1988-11-10 1989-11-06 Lactamimides in the treatment of drug-resistant protozoal infections Ceased AU619613B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26985888A 1988-11-10 1988-11-10
US269858 1988-11-10

Publications (2)

Publication Number Publication Date
AU4445089A AU4445089A (en) 1990-05-17
AU619613B2 true AU619613B2 (en) 1992-01-30

Family

ID=23028945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44450/89A Ceased AU619613B2 (en) 1988-11-10 1989-11-06 Lactamimides in the treatment of drug-resistant protozoal infections

Country Status (11)

Country Link
EP (1) EP0370320B1 (enExample)
JP (1) JPH02256614A (enExample)
AT (1) ATE81004T1 (enExample)
AU (1) AU619613B2 (enExample)
DE (1) DE68903092T2 (enExample)
DK (1) DK561089A (enExample)
ES (1) ES2045348T3 (enExample)
GR (1) GR3006349T3 (enExample)
IE (1) IE893618L (enExample)
PH (1) PH27568A (enExample)
ZA (1) ZA898440B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
WO1995011014A1 (en) * 1993-10-21 1995-04-27 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors
KR100342275B1 (ko) * 1993-10-21 2002-12-05 지.디. 썰 엘엘씨 산화질소신타제저해제로서유용한아미디노유도체
PT749418E (pt) * 1994-03-10 2001-01-31 Searle & Co Derivados de l-n6-(1-iminoetil)lisina uteis como inibidores de oxido nitrico sintetase
US5684008A (en) * 1994-11-09 1997-11-04 G. D. Searle & Co. Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
JPH11504319A (ja) * 1995-04-20 1999-04-20 ジー．ディー．サール アンド カンパニー 酸化窒素シンターゼインヒビターとして有用な環状アミジノ薬剤
US5830917A (en) * 1995-09-11 1998-11-03 G. D. Searle & Co. L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5981511A (en) * 1996-03-06 1999-11-09 G.D. Searle & Co. Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
AU4821799A (en) 1998-06-10 1999-12-30 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
CN102149679A (zh) * 2008-09-09 2011-08-10 巴斯夫欧洲公司 用于防治动物害虫的吡咯啉-2-基氨基化合物
CA2746295A1 (en) * 2008-12-08 2010-07-08 Allergan, Inc. N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
WO2011042565A2 (en) * 2009-10-09 2011-04-14 Instituut Voor Tropische Geneeskunde Antiprotozoal activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228130A (en) * 1978-10-23 1980-10-14 The B. F. Goodrich Company Coating polymerization reactors with oligomers derived from polyhydric phenols plus a bleach

Also Published As

Publication number Publication date
IE893618L (en) 1990-05-10
GR3006349T3 (enExample) 1993-06-21
ZA898440B (en) 1990-07-25
EP0370320A1 (en) 1990-05-30
DK561089D0 (da) 1989-11-09
DK561089A (da) 1990-05-11
DE68903092T2 (de) 1993-02-18
EP0370320B1 (en) 1992-09-30
ES2045348T3 (es) 1994-01-16
AU4445089A (en) 1990-05-17
ATE81004T1 (de) 1992-10-15
DE68903092D1 (de) 1992-11-05
JPH02256614A (ja) 1990-10-17
PH27568A (en) 1993-08-18

Similar Documents

Publication Publication Date Title
EP0370320B1 (en) Lactamimides in the treatment of drug-resistant protozoal infections
CA2212548C (en) Use of carbazole compounds for the treatment of congestive heart failure
US5166202A (en) Method for the treatment of panic disorder
SK17392001A3 (sk) Použitie zlúčenín ako antibakteriálnych činidiel
US4260615A (en) Antimalarial compositions
US5134168A (en) Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections
CA2150694A1 (en) Antioxydant cardioprotective use of, and method of treatment using, hydroxycarbazole compounds
US5011841A (en) Treatment of depression
HUP9904638A2 (hu) Szubsztituált benzopiránszármazékok alkalmazása gyógyszerkészítmények előállítására
US20260000635A1 (en) THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING FP AGONIST AND ß BLOCKER
AU625071B2 (en) N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
SK282039B6 (sk) Oftalmický prípravok na liečenie očnej hypertenzie obsahujúci kombináciu inhibítora karboanhydrázy a beta-adrenergného antagonistu
WO1998050028A1 (en) Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
AR026631A1 (es) ''3-4-dihidroquinazolinas 5,6-disustituidas''
US5373005A (en) Despiramine in the treatment of drug-resistant malarial infections
CN100546581C (zh) 用于治疗神经病学病症的包含抗癫痫药的组合
JP2001507672A (ja) Ｃｉｓ―縮合シクロペンテノ―１，２，４―トリオキサン誘導体を含有する抗マラリア組成物
US7872035B2 (en) Angiotensin II antagonists
US5182387A (en) Bis-dibenzoazepine compounds
CA2150695A1 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds
LV13281B (en) Citalopram for the treatment of elevated blood pressure
Shaikh et al. Therapeutic efficacy of Allopurinol (zyloric) in Cutanoues Leishmaniasis
IT8148605A1 (it) L'applicazione in terapeutica dei 4-arilchinazolin-2(1H)-oni per il trattamento della dismenorrea
JPH0331254A (ja) マラリアの予防及び治療に有用なジスタマイシンａ及びその誘導体